MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 03.02.2026
Teva Pharmaceutical Industries Limited Kurshistorie 2011-2026 | TEVA
Kurshistorie Jährlich Teva Pharmaceutical Industries Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.1 | 17.3 | 13 | 10.3 | 8.43 | 11.8 | 10.4 | 19.9 | 20.3 | 32 | 57.5 | 52 | 39.6 | 32.7 | 38 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 57.5 | 8.43 | 26.6 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Akebia Therapeutics
AKBA
|
1.37 | $ 1.48 | -1.67 % | $ 277 M |  USA |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Amarin Corporation plc
AMRN
|
1.08 | $ 14.7 | -0.34 % | $ 5.99 B |  Irlanda |
 |
ANI Pharmaceuticals
ANIP
|
61.9 | $ 79.9 | -0.55 % | $ 1.54 B | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M |  Canada |
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.88 | 5.24 % | $ 4.8 M |  China |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | China |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Adagene
ADAG
|
1.56 | $ 2.66 | -0.37 % | $ 150 M | China |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.5 | -2.1 % | $ 8.42 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 110.96 | 0.56 % | $ 27.2 B | Germany |
 |
Cabaletta Bio
CABA
|
17.5 | $ 2.48 | 1.64 % | $ 2.9 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Compugen Ltd.
CGEN
|
1.65 | $ 1.75 | 2.05 % | $ 157 M |  Israel |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Ascendis Pharma A/S
ASND
|
153 | $ 220.07 | -0.88 % | $ 5 B |  Danmark |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
63.4 | $ 41.12 | -0.46 % | $ 4.24 B | USA |
 |
Burford Capital Limited
BUR
|
10.6 | $ 9.23 | 2.9 % | $ 1.44 B | Britain |
 |
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
Catalyst Pharmaceuticals
CPRX
|
20.6 | $ 24.29 | -0.67 % | $ 2.88 B | USA |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
39.6 | $ 49.94 | 0.48 % | $ 4.21 B |  Schweiz |
|
Champions Oncology
CSBR
|
7.75 | $ 6.54 | -0.15 % | $ 89.3 M | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 4.45 | 5.33 % | $ 9.68 B | Israel |
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.46 | - | $ 373 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
5.91 | $ 14.48 | -0.28 % | $ 4.47 B | USA |